速尿
利尿剂
重症监护医学
医学
利尿剂
低钠血症
重症医师
高钠血症
乙酰唑胺
代谢性碱中毒
急性肾损伤
重症监护
内科学
化学
钠
有机化学
作者
Victor Joaquin Escudero,Jordi Mercadal,Alícia Molina‐Andújar,Gastón J. Piñeiro,David Cucchiari,Adriana Jacas,Albert Carramiñana,Esteban Poch
出处
期刊:Frontiers in nephrology
[Frontiers Media SA]
日期:2022-07-08
卷期号:2
被引量:1
标识
DOI:10.3389/fneph.2022.879766
摘要
Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used with good results in patients with selected profiles. From acetazolamide to tolvaptan, we will discuss recent studies and highlight how specific diuretic mechanisms could help to manage different ICU problems, such as loop diuretic resistance, hypernatremia, hyponatremia, or metabolic alkalosis. The current review tries to shed some light on the potential use of non-loop diuretics based on patient profile and give recommendations for loop diuretic treatment performance focused on what the intensivist and critical care nephrologist need to know based on the current evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI